A sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione DMF (Drug Master File) is a document detailing the whole manufacturing process of sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione active pharmaceutical ingredient (API) in detail. Different forms of sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione DMFs exist exist since differing nations have different regulations, such as sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione DMF submitted to regulatory agencies in the US is known as a USDMF. sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione USDMF includes data on sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sodium 1,3-dichloro-1,3-diaza-5-azanidacyclohexane-2,4,6-trione suppliers with USDMF on PharmaCompass.